MedTrace Logo

Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas

NCT04248959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2023-12-27

No results posted yet for this study

Summary

The purpose of this study was to evaluate the feasibility of a multimodal prehabilitation intervention intended to optimize postoperative recovery in adolescents and young adults (AYAs) diagnosed with soft tissue and bone-based sarcomas of the upper and lower extremities (extremity sarcomas; ES).

Conditions

Interventions

BEHAVIORAL

Multimodal prehabilitation

Multimodal Prehabilitation * Aerobic exercise * Home-based, high-intensity interval training (HIIT), 2 days/week * Home-based, moderate-intensity continuous training (MICT), 2-3 days/week * Resistance exercise * Home-based, moderate-intensity resistance training, 2-3 d/wk, all major muscle groups (working around tumour-related deficits), 8-10 exercises, 12-15 repetitions, resistance bands and body weight based * Nutrition * Protein intake 1.2-1.5 g/kg body weight/day in compliance with European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines * Stress management * Daily mindfulness practice, 20 min/session, guided by audio file created at Mount Sinai Hospital

Sponsors & Collaborators

  • MOUNT SINAI HOSPITAL

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Daniel R Santa Mina, PhD · University of Toronto; University Health Network

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-02
Primary Completion
2023-04-26
Completion
2023-04-26

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248959 on ClinicalTrials.gov